First Time Loading...

Aveo Pharmaceuticals Inc
NASDAQ:AVEO

Watchlist Manager
Aveo Pharmaceuticals Inc Logo
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Watchlist
Price: 15 USD
Updated: May 16, 2024

Net Margin
Aveo Pharmaceuticals Inc

-30.8%
Current
-194%
Average
-8.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-30.8%
=
Net Income
-29m
/
Revenue
94.3m

Net Margin Across Competitors

Country US
Market Cap 519.3m USD
Net Margin
-31%
Country US
Market Cap 289.2B USD
Net Margin
9%
Country US
Market Cap 171.1B USD
Net Margin
13%
Country US
Market Cap 112.7B USD
Net Margin
37%
Country US
Market Cap 107.8B USD
Net Margin
29%
Country AU
Market Cap 138.6B AUD
Net Margin
17%
Country US
Market Cap 83.5B USD
Net Margin
2%
Country US
Market Cap 49.4B USD
Net Margin
-116%
Country US
Market Cap 43.1B USD
Net Margin
-33%
Country US
Market Cap 34.3B USD
Net Margin
12%
Country KR
Market Cap 39.6T KRW
Net Margin
25%

Profitability Report

View the profitability report to see the full profitability analysis for Aveo Pharmaceuticals Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-30.8%
=
Net Income
-29m
/
Revenue
94.3m
What is the Net Margin of Aveo Pharmaceuticals Inc?

Based on Aveo Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of -30.8%.